Vaxxinity, Inc.
VAXX · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $108 | $176 | $703 | $2,076 |
| - Cash | $5 | $33 | $145 | $31 |
| + Debt | $15 | $15 | $11 | $38 |
| Enterprise Value | $118 | $157 | $569 | $2,083 |
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | -100% | -88.2% | – |
| Gross Profit | -$2 | -$2 | -$2 | $1 |
| % Margin | – | – | -2,834.8% | 90.7% |
| EBITDA | -$54 | -$73 | -$135 | -$38 |
| % Margin | – | – | -204,898.5% | -6,832.7% |
| Net Income | -$0 | -$75 | -$137 | -$40 |
| % Margin | – | – | -207,840.9% | -7,173.6% |
| EPS Diluted | -0.001 | -0.6 | -1.09 | -0.32 |
| % Growth | 99.9% | 45% | -240.6% | – |
| Operating Cash Flow | -$57 | -$56 | -$81 | -$34 |
| Capital Expenditures | -$1 | -$2 | -$1 | -$1 |
| Free Cash Flow | -$58 | -$58 | -$82 | -$35 |